Norwegian invention to fight antibiotic resistance
A new Norwegian technology may help stop the increase of antibiotic multi-resistance.
Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.
She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.
A new Norwegian technology may help stop the increase of antibiotic multi-resistance.
The first-year students of the Researcher Programme met their mentors.
IMPRESS Norway, a national clinical study for cancer precision medicine, will begin in 2021.
These are some of the main points for cancer innovation in the newly released state budget.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.